PMA device
iStent inject Trabecular MicroBypass System
Glaukos Corporation · Intraocular Pressure Lowering Implant (OGO, Class III) · First FDA decision Jun 21, 2018, newest Jan 13, 2025Glaucoma
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
10
Naming "iStent inject Trabecular"
MAUDE reports
228
Brand "iStent inject Trabecular", since 2015
PubMed studies
34
Mentioning "iStent inject Trabecular"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing iStent inject Trabecular MicroBypass System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- iStent inject Trabecular MicroBypass SystemPMA supplement
P170043-S020 · Decided Jan 13, 2025 · 179 days after receipt · Normal 180 Day Track No User Fee
Device type: Intraocular pressure lowering implant (OGO) · Ophthalmology
- iStent inject Trabecular Micro-Bypass SystemPMA supplement
P170043-S008 · Decided Mar 3, 2021 · 86 days after receipt · Normal 180 Day Track No User Fee
Device type: Intraocular pressure lowering implant (OGO) · Ophthalmology
- iStent inject Trabecular Micro-Bypass SystemPMA supplement
P170043-S007 · Decided Apr 30, 2020 · 58 days after receipt · Normal 180 Day Track No User Fee
Device type: Intraocular pressure lowering implant (OGO) · Ophthalmology
3 more FDA decisions with a free account
Older decisions: P170043-S001, P170043
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Pulmonary Artery Pressure Sensors for Heart Failure ManagementNational determinationOn the books20.36Updated Oct 6, 2026
- Implantable Pulmonary Artery Pressure Sensors for Heart Failure ManagementNational analysisReview closedCAG-00466NUpdated Sep 18, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "iStent inject Trabecular", any status and sponsor, newest update first.
Sight Sciences, Inc.Not on our public-company list
NCT04658095 · 10 participants · Start Jan 11, 2022 · Primary completion Nov 18, 2022
Device: Canaloplasty and trabeculotomy with the OMNI system.; iStent inject and 1 more · For: Glaucoma, Open-Angle
Sites: Frankfurt, Germany; Barcelona, Spain; Valencia, Spain · 5 sites in all
Diablo Eye AssociatesNot on our public-company list
NCT05583591 · 58 participants · Start Oct 1, 2022 · Primary completion Apr 22, 2024
Device: Combined cataract surgery with Hydrus microstent; Combined cataract surgery with iStent Inject W · For: Open Angle Glaucoma
Sites: Walnut Creek, California
- iStent Inject New Enrollment Post-Approval StudyStatus unknown
Glaukos CorporationPublic (GKOS)
NCT04624698 · 358 participants (planned) · Start Sep 22, 2020 · Primary completion May 2026
Device: iStent Inject Implantation · For: Glaucoma, Open-Angle; Glaucoma
Sites: Phoenix, Arizona; Torrance, California; Dallas, Texas
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "iStent inject Trabecular", and for the whole product code for context.
This brand
228 reports: 62 malfunction, 166 injury, 0 death
Whole product code OGO
2,634 reports: 667 malfunction, 1,967 injury, 0 death
Newest reports for this brand
- iStent Inject Trabecular Micro-Bypass SystemMalfunction
2032546-2026-00098 · Received Oct 21, 2026 · Event dated Sep 29, 2026
Device type: Intraocular Pressure Lowering Implant (OGO)
Device problem as coded: Obstruction of Flow
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- iStent Inject Trabecular Micro-Bypass SystemMalfunction
2032546-2026-00092 · Received Oct 6, 2026 · Event dated Sep 16, 2026
Device type: Intraocular Pressure Lowering Implant (OGO)
Device problem as coded: Obstruction of Flow; Device Dislodged or Dislocated
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2032546-2026-00091 · Received Oct 1, 2026 · Event dated Sep 16, 2026
Device type: Intraocular Pressure Lowering Implant (OGO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hyphema
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "iStent inject Trabecular"[tiab]. The summary above synthesizes these.
- iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control.
Hengerer FH, Auffarth GU, Conrad-Hengerer I · Adv Ther · 2022Research Support, Non-U.S. Gov't
- iStent inject trabecular microbypass stent implantation with cataract extraction in open-angle glaucoma: early clinical experience.
Ferguson TJ, Dockter Z, Bleeker A, et al. · Eye Vis (Lond) · 2020
- iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes.
Berdahl J, Voskanyan L, Myers JS, et al. · Clin Exp Ophthalmol · 2020
- Position of the ISTENT Inject® Trabecular Micro-Bypass System Visualized with the NIDEK GS-1 Gonioscope-A Postoperative Analysis.
Zimmermann JA, Storp JJ, Merté RL, et al. · J Clin Med · 2023
- Safety and efficacy of iStent Inject trabecular micro-bypass stents in combination with phacoemulsification for chronic open angle glaucoma associated with cataract.
Cela D, Brasnu E, Hamard P, et al. · J Fr Ophtalmol · 2023
- 7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined and Standalone Usage.
Hengerer FH, Auffarth GU, Conrad-Hengerer I · Adv Ther · 2024Research Support, Non-U.S. Gov't
- Combined iStent® Inject Trabecular Micro-Bypass and Phacoemulsification in Australian Patients with Open-Angle Glaucoma.
Salby AM, Skalicky SE · Clin Ophthalmol · 2020
- Efficacy and Safety of Pairing iStent Inject Trabecular Micro-Bypass and iAccess Precision Blade Goniotomy in Patients with Open-Angle Glaucoma.
Gallardo MJ, Porter M · Ophthalmol Ther · 2023
- Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye.
Kiessling D, Rennings C, Hild M, et al. · Clin Exp Ophthalmol · 2023
- Mid-Term Evaluation of iStent Inject® Trabecular Micro-Bypass Stent Implantation with or without Phacoemulsification: A Retrospective Study.
Silveira Seixas RC, Balbino M, Basile Neto A, et al. · Clin Ophthalmol · 2020
- Evaluation of iStent Inject® Trabecular Microbypass Stent Implantation With Phacoemulsification in Cases of Mild to Moderate Primary Open-Angle Glaucoma (POAG).
Alkhusheh A, Zakri R, Abdelhady M · Cureus · 2025
- Real-world Case Series of iStent or iStent inject Trabecular Micro-Bypass Stents Combined with Cataract Surgery.
Manning D · Ophthalmol Ther · 2019
Other devices of this type
Also filed under product code OGO.
- iStent Trabecular Micro-Bypass Stent System, iStent inject Trabecular Micro-Bypass System, iStent inject W Trabecular MiGlaukos Corporation · PMA 2022
- Hydrus MicrostentAlcon Research, LLC · PMA 2025
- iStent inject® W Trabecular Micro-Bypass System Model iS2Glaukos Corporation · PMA 2025
- CyPass System 241-SAlcon Research, Ltd. · PMA 2018
- Glaukos Trabecular Micro Bypass Stent Model GTS100R/LGlaukos Corporation · PMA 2013
- CyPass Micro-StentAlcon Research, Ltd. · PMA 2020
- iStent® Trabecular Mjcro-Bypass Stent System, Model GTS100Glaukos Corporation · PMA 2024
- Hydrus MicrosentAlcon Research, LLC · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.